Zantac Alternative Drugs Recommended By The FDA May Cause Memory Loss

The side effects of protein pump inhibitor drugs may include temporary or permanent memory loss

Tuesday, October 27, 2020 - The latest and greatest problem that plagues protein pump inhibitor drugs is patient memory loss. Researchers are unclear whether or not the memory loss is temporary as studies have only been performed in the short term. Clinical trials at Ohio State University by Clinical Psychology Researcher Annelise Madison discovered, "memory problems were between 20% and 29% more severe than those reported by patients who didn't use PPI's," according to WQAD8.com, a news station in Davenport, Iowa. The implication is that the longer one uses PPIs the more severe and long-lasting memory loss could be. Zantac stomach cancer lawsuit attorneys offer a free no obligation consultation to families and people that developed stomach cancer from taking the antacid Zantac.

The US Food and Drug Administration (FDA) initially recommended that people stop taking Zantac (ranitidine), an H2 histamine blocker, and switch to another class of drugs called protein pump inhibitors (PPIs). The best selling PPI drugs include brand names Prilosec, Prevacid, and Nexium. These drugs did not test positive, unlike Zantac, for elevated levels of a cancer-causing substance called N-Nitrosodimethylamine (NDMA), and are still on the market.

NDMA is a carcinogenic byproduct of industrial production commonly found in low levels in the air, land, and water. Online drug testing pharmacy Valisure tested Zantac and found levels of NDMA over 1 million nanograms (ngs) per capsule, far exceeding the FDA guidelines of 96 ngs. Valisure immediately reported their findings to the FDA prompting Sanofi, the maker of Zantac to recall the world's best selling anti-heartburn and acid reflux medicine. The FDA recalled all ranitidine products about a month later.

PPI drugs have a long list of side effects, not the least of which is contributing to type-2 diabetes. A British medical journal has linked the long-term use of Protein Pump Inhibitors to an increased risk of developing Type-2 diabetes.

According to Diabetes In Control.com, "long-term PPI users (>2 years) have a 24% higher risk of developing diabetes compared to non-PPI users," according to the BMJ. Also, PPI drugs (may cause) other medical problems including, "... an increased risk of bone fractures, chronic kidney disease, gut infections such as C. difficile, vitamin B12 deficiency, and stomach cancer."

Zantac was recalled by the FDA earlier in 2020 due to finding accelerated levels of NDMA many thousands of times greater than the level thought to be safe. The FDA recommended the switch to PPI drugs, but those drugs are quickly turning out to have life-threatening problems of their own. The FDA is now caught between a rock and a hard place because to recall PPI drugs would mean that heartburn and acid reflux sufferers would have nothing to turn to besides living a more healthy lifestyle to try and curb their indigestion. Individuals have developed a variety of cancer allegedly from taking Zantac like stomach, bladder, esophagus, prostate, and breast cancer. Many have hired Zantac cancer lawyers to help them file a claim against Sanofi for failing to warn them of the health consequences of the medicine.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.